Cargando…
Exploring metabolomics biomarkers for evaluating the effectiveness of concurrent radiochemotherapy for cervical cancers
BACKGROUND: Cervical cancer is the second most common female malignancy worldwide. The main method to evaluate the effect of concurrent chemoradiotherapy (CCRT) in the locally advanced stage is imaging which cannot meet the clinical needs. This study aimed to explore potential cervical cancer biomar...
Autores principales: | Zhou, Huihui, Li, Qi, Wang, Tong, Liang, Hong, Wang, Yanan, Duan, Yani, Song, Min, Wang, Yaoxian, Jin, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797309/ https://www.ncbi.nlm.nih.gov/pubmed/35117632 http://dx.doi.org/10.21037/tcr.2020.02.49 |
Ejemplares similares
-
Prognostic biomarkers of cervical squamous cell carcinoma identified via plasma metabolomics
por: Zhou, Huihui, et al.
Publicado: (2019) -
Prognosis of stage III cervical cancer: a two-way outcome study
por: Zhou, Huihui, et al.
Publicado: (2020) -
Surgery followed by concurrent radiochemotherapy as treatment for patients with locally recurrent cervical cancer
por: Zhang, Xiang, et al.
Publicado: (2021) -
Clinical study of nimotuzumab combined with concurrent radiochemotherapy for treatment of locally advanced cervical cancer
por: Chen, Wenli, et al.
Publicado: (2019) -
Concurrent radiochemotherapy in advanced hypopharyngeal cancer
por: Krstevska, Valentina, et al.
Publicado: (2010)